In a significant operation, Telangana’s Drugs Control Administration (DCA) seized counterfeit antibiotics valued at ₹1.33 crore during a raid on a pharmaceutical facility at Biotech Park in Karakapatla, Siddipet district. The company was allegedly exporting drugs manufactured by other firms to Russia under fraudulent labels.
Acting on credible information, DCA officials conducted the raid on November 26, uncovering large stocks of mislabelled antibiotics stored in the Finished Goods Warehouse. The drugs were found to be in violation of the Drugs and Cosmetics Act, 1940.
Among the seized items was a batch of Ampicillin Sulbactam injections (Batch No. JD4479), falsely labelled as being produced by Jodas Expoim Pvt. Ltd. and Alpa Laboratories, Indore. Investigations revealed the batch had been manufactured by a separate company based in Cherlapally, Telangana.
Further inspections uncovered other mislabelled antibiotics, including Amoxicillin and Meropenem, which had already been exported to Russia in October and November under the guise of being produced by the accused company.
As reported by indiatoday.in, the operation was spearheaded by Assistant Director P. Ramu, along with Drugs Inspectors S. Vinay Sushmi, Karthik Siva Chaitanya, T. Shiva Teja, and P. Chandrakala. Samples of the seized drugs have been sent for analysis, and investigations are ongoing. Officials confirmed that legal action will be taken against those involved.
The DCA has been intensifying its efforts against illegal and overpriced pharmaceutical sales in Telangana. Earlier this year, in February and March, the agency uncovered several such illegal operations:
- On February 20, the DCA seized 118 kg of illicit drugs worth ₹5.5 lakh from a Hyderabad-based pharmaceutical company that had been ordered to cease production a year earlier.
- On February 27, authorities confiscated large quantities of overpriced antibiotic injection vials in Nizamabad district, which were being sold at nearly double the government-sanctioned price.
The DCA remains committed to combating the production and sale of counterfeit and overpriced drugs in the state.